A hepatic graft tuberculosis transmitted from a living-related donor

Transplantation

Volumn 63, Issue 6, 1997, Pages 905-907

  Kiuchi, Tetsuya ^a   Inomata, Yukihiro ^a   Uemoto, Shinji ^a   Satomura, Kazunari ^a   Egawa, Hiroto ^a   Okajima, Hideaki ^a   Yamaoka, Yoshio ^a   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STEROID; STREPTOMYCIN; TACROLIMUS;

ARTICLE; BILE DUCT ATRESIA; CASE REPORT; DISEASE TRANSMISSION; FEMALE; GRAFT INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LIVER TRANSPLANTATION; LIVING DONOR; PNEUMONIA; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MOTHERS; POSTOPERATIVE COMPLICATIONS; RIFAMPIN; TACROLIMUS; TUBERCULOSIS;

EID: 0030950101     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703270-00019     Document Type: Article

References (12)

1. Morimoto T, Awane M, Tanaka A, et al. Analysis of functional abnormalities uncovered during preoperative evaluation of donor candidates for living-related liver transplantation. Clin Transplant 1995; 9: 60.
2. Hodes DS, Bottone EJ, Hass A, Hodes HL. Reaction of Bacillus subtilis products with amebocyte lysates of Japanese horseshoe crab, Tachypleus tridentatus. J Clin Microbiol 1988; 26: 890.
3. Sano K, Tanaka K, Uemoto S, et al. Cytomegalovirus infection in living related liver transplantation: rapid diagnosis by human monoclonal antibody staining of blood leukocytes. Transplant Sci 1994; 4: 105.
4. Gottesdiener KM. Transmitted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989; 110: 1001.
5. Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994; 58: 301.
6. Qunibi WY, Al-Sibai MB, Taher S, et al. Mycobacterial infection after renal transplantation: report of 14 cases and review of the literature. Q J Med 1990; 77: 1039.
7. Lombardi G, Del Gallo F, Vismara D, Piccolella E, Colizzi V. Immunology of tuberculosis: new directions in research. Ric Clin Lab 1987; 17: 1.
8. Furlan V, Perello L, Jacquemin E, Debray D, Taburet A-M. Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. Transplantation 1995; 58: 1217.
9. McDiarmid SV, Colonna JO II, Shaked A, Vargas J, Ament ME, Busttil RW. Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. Tranplantation 1993; 55: 1328.
10. McAllister AC, Thompson PJ, Al-Habet SM, et al. Rifampin reduced effectiveness and bioavailability of prednisolone. Br Med J 1983; 286: 923.
11. Egaw H, Esquivel CO, So SK, Cox K, Concepcion W, Lawrence L. FK506 conversion therapy in pediatric liver transplantation. Transplantation 1994; 57: 1169.
12. Iwasaki K, Shiraga T, Matsuda H, et al. Further metabolism of FK506 (tacrolimus): identification and biological activities of the metabolites oxidized at multiple sites of FK506. Drug Metab Dispos 1995; 23: 28.